Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Ambry Genetics Initiates Fluidigm-Based Genomic Research Services

Published: Friday, April 13, 2012
Last Updated: Friday, April 13, 2012
Bookmark and Share
Gene expression, SNP genotyping and sample prep for targeted sequencing.

Ambry Genetics announced the launch of Fluidigm BioMark™ HD and Access Array™ System-based genomic research services. These services provide gene expression, SNP genotyping, and sample preparation for targeted sequencing using next-generation sequencers, focused on the genomics research market.

The BioMark HD System is one of the most advanced genomic analysis instruments on the market today. It provides the sensitivity and throughput needed to study gene expression profiles down to the single-cell level, as well as high throughput SNP genotyping and digital PCR for copy number variation and rare mutation detection. The Access Array System enables high-throughput, target-enrichment for all of the major next-generation sequencing instruments and allows users to enrich multiple unique targets (such as exons) from a large number of samples, all at one time and at low cost.

Ambry Genetics offers a wide variety of genomic services that will be enhanced by the addition of Fluidigm platforms. Separately, from a regulatory standpoint Ambry can offer its other services within a CLIA setting and deliver the highest quality of data, while handling large volumes of samples with automation in place.

“For months, many of our genomics customers have been clamoring for Fluidigm technologies from single-cell gene expression to sample prep for targeted resequencing. We are ready to unleash the power of Fluidigm platforms and are anxious to offer our customers these enhanced capabilities,” said Charles Dunlop, Chief Executive Officer of Ambry Genetics. “Over the past decade, Ambry Genetics has developed one of the best reputations in the genomics industry, and a big reason is our many technology platforms and our technical abilities to apply them. Having the Fluidigm technology in house is a major step forward for us, and will continue to solidify Ambry’s reputation as a leader in this space,” Dunlop concluded.

"Ambry Genetics has a first-class reputation as an adopter of leading technologies. We at Fluidigm are thrilled that our products will be part of Ambry's portfolio of services, and we are excited about the prospect of working closely together. With the combined expertise, customer focus, and technological prowess of Fluidigm and Ambry, we are confident we will deliver a new level of value to Ambry's customers," said Gajus Worthington, President and Chief Executive Officer of Fluidigm.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Quick, Early Test For Ebola Could Prevent Epidemics
Researchers from Princeton University are collaborating with U.S. government labs to develop a more rapid, accurate and inexpensive test for the Ebola virus with the aim of identifying infections before carriers become symptomatic and contagious.
From Super to Ultra-Resolution Microscopy
A new method pushes the frontier in imaging resolution, with the potential to distinguish individual features in single molecules.
Cancer Research UK joins forces with U.S. 'Cancer Moonshot'
Cancer Research UK and the US government’s National Cancer Institute have announced that two teams will work together to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice President Joe Biden’s Cancer Moonshot.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Measuring the Abundance of Extremely Rare Mutations
Researchers from Rutgers University demonstrate the use of multiplex real-time PCR assays to measure the abundance of extremely rare mutations associated with cancer.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!